ConductScience.org, home

Paper668789

Pharmacokinetic approach to intravenous procainamide therapy.

Lima JJ and 4 others. Eur J Clin Pharmacol, 1978. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic approach to intravenous procainamide therapy. Papers, record 668789. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/668789

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic approach to intravenous procainamide therapy.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.06
iCite
Revised in PubMed
2019-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lima JJJ J
2Conti DRD R
3Goldfarb ALA L
4Golden LHL H
5Jusko WJW J

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProcainamideMajor topic
Acetylation
Biotransformation
Humans
Injections, Intravenous
Kinetics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14900236Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.N Engl J Med1969https://conductscience.org/library/papers/4900236PubMed
31261157N-Acetylprocainamide levels in patients with end-stage renal failure.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261157PubMed
44150137The acetylator phenotype of patients with systemic lupus erythematosus.Drug Metab Dispos1974https://conductscience.org/library/papers/4150137PubMed
55107621Procainamide dosage schedules, plasma concentrations, and clinical effects.JAMA1971https://conductscience.org/library/papers/5107621PubMed
61153866The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.Res Commun Chem Pathol Pharmacol1975https://conductscience.org/library/papers/1153866PubMed
8832652Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/832652PubMed
101185521Pharmacokinetics in man of the N-acetylated metabolite of procainamide.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1185521PubMed
11776488Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.Clin Pharmacol Ther1976https://conductscience.org/library/papers/776488PubMed
124683748Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.Ann Intern Med1973https://conductscience.org/library/papers/4683748PubMed
13618707Determination of procainamide acetylator status.Clin Pharmacol Ther1978https://conductscience.org/library/papers/618707PubMed
14322922Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions.Clin Pharmacol Ther1977https://conductscience.org/library/papers/322922PubMed
15237647Polymorphic acetylation procainamide in man.Clin Pharmacol Ther1975https://conductscience.org/library/papers/237647PubMed
16954350Relationship between the pharmacokinetics and pharmacodynamics of procainamide.Clin Pharmacol Ther1976https://conductscience.org/library/papers/954350PubMed
171122681Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122681PubMed
184420442A safe method for rapidly achieving plasma concentration plateaus.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4420442PubMed
1922216524Acetylator phenotype and the clinical pharmacology of slow-release procainamide.Br J Clin Pharmacol1976https://conductscience.org/library/papers/22216524PubMed
204613464Clinical application of the pharmacokinetics of procaine amide.Cardiovasc Clin1974https://conductscience.org/library/papers/4613464PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
7439250Effect of procainamide on left ventricular performance in patients with primary myocardial disease.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7439250PubMed
6509861Population pharmacokinetics of procainamide from routine clinical data.Clin Pharmacokinet1984https://conductscience.org/library/papers/6509861PubMed
6380870Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.Clin Pharmacokinet1984https://conductscience.org/library/papers/6380870PubMed
458558Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/458558PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/668789

GET https://conductscience.org/api/papers/v1/668789/authors